Zolmitriptan

• Background :

  Potent and selective serotonin 5HT 1B/1D agonist (Ki=0.63 and 5.01 nM for 5HT 1D and 1B respectively.1 Displays proven efficacy for the treatment of migraine.2 Inhibits neurogenic inflammation and pain during electrical stimulation in human skin.3 Induces nerve growth, integration and function in transplanted heterologous organs in regenerative medicine.4

• Conjugation :

  Unconjugated

• Buffer :

  White solid

• Storage Conditions :

  -20°C